That is below the 30% rate reported at an interim stage of the study at the International Liver Congress earlier this year, but still sufficient for GSK to take the drug forward into a phase 3 ...

However, the result has cemented GSK's view that dostarlimab can become the "backbone" of its immuno-oncology R&D programmes ... reporting that the phase 2/3 COSTAR trial of Jemperli with ...

Nov. 1, 2024 — Biomedical engineers have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Copyright © 2024 MarketWatch, Inc. All rights reserved.

June 3, 2024 — Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require ...

American Electric Power Co. Inc.-4.13% $51.22B ...

"A Quiet Place 3" is still in the works, and no we aren't talking about the spin-off prequel "A Quiet Place: Day One" that premiered in theaters over the summer. Continuing the story of a world ...